Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Fig. 4

Canadian Cardiovascular Society and New York Heart Association classes over 12-month follow-up. a Canadian Cardiovascular Society (CCS) class changes from 6 and 12 months to baseline (n = 8). b New York Heart Association (NYHA) class changes from 6 and 12 months to baseline (n = 10). Data presented as mean ± SD. **p ≤ 0.01, ***p ≤ 0.001. §§§p ≤ 0.001 vs baseline

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512